• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Toolbar - View Selection
 
Items 1 of 1
ALX-270-390 Revised 09-Jan-08
Bohemine
Add to Clipboard
SYNONYMS 6-Benzylamino-2-(3-hydroxypropylamino)-9-isopropylpurine
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-390-M001   1 mg 40.00 USD Add To Cart
ALX-270-390-M005   5 mg 120.00 USD Add To Cart
Product Specification
FORMULA: C18H24N6O
MW: 340.4
CAS NUMBER: 189232-42-6
PURITY: ≥97% (HPLC)
APPEARANCE: White to off-white crystalline solid.
SOLUBILITY: Soluble in DMSO, dimethyl formamide, 100% ethanol or methanol.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
HANDLING: Protect from moisture.

Product Description
Cell permeable inhibitor of CDK1 (IC50=1.1µM) and CD2 (IC50=600nM). Arrests cell cycle in the G1/S boundary and activates mature bovine oocytes.
Product Specific Literature References
Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds: L. Havlicek, et al.; J. Med. Chem. 40, 408 (1997) Abstract
Treatment of Vicia faba root tip cells with specific inhibitors to cyclin-dependent kinases leads to abnormal spindle formation: P. Binarova, et al.; Plant J. 16, 697 (1998) Abstract
Activation of bovine oocytes by specific inhibition of cyclin-dependent kinases: R. Alberio, et al.; Mol. Reprod. Dev. 55, 422 (2000) Abstract
Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine: H. Kovarova, et al.; Electrophoresis 21, 3757 (2000) Abstract
In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic route: Z. Chmela, et al.; Drug. Metab. Dispos. 29, 326 (2001) Abstract; Full Text
Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases: K. Vermeulen, et al.; Leukemia 16, 299 (2002)
Further Categories Containing This Product:
Cell Cycle Blockers & Inhibitors/Related Products
 
 

Your items will be kept only for the duration of your visit.